A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer

NCT01200212 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
432
Enrollment
OTHER
Sponsor class

Stopped A planed interim analysis shows no benefits, but higher adverse event rates for the experimental arm.

Conditions

Interventions

Sponsor

GBG Forschungs GmbH